Drug resistance: Still a daunting challenge to the successful treatment of AML
Top Cited Papers
- 1 February 2012
- journal article
- review article
- Published by Elsevier in Drug Resistance Updates
- Vol. 15 (1-2) , 62-69
- https://doi.org/10.1016/j.drup.2012.02.001
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health
- National Cancer Institute
This publication has 90 references indexed in Scilit:
- Zosuquidar, a novel modulator of P-glycoprotein, does not improve the outcome of older patients with newly diagnosed acute myeloid leukemia: a randomized, placebo-controlled trial of the Eastern Cooperative Oncology Group 3999Blood, 2010
- Nuclear reprogramming to a pluripotent state by three approachesNature, 2010
- Cancer stem cells: mirage or reality?Nature Medicine, 2009
- A synonymous polymorphism in a common MDR1 (ABCB1) haplotype shapes protein functionBiochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2009
- Induced Pluripotent Stem Cell Lines Derived from Human Somatic CellsScience, 2007
- Methylation-Controlled J Protein Promotes c-Jun Degradation To Prevent ABCB1 Transporter ExpressionMolecular and Cellular Biology, 2007
- CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older ageAnnals of Hematology, 2007
- CD33 expression and P-glycoprotein–mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapyBlood, 2007
- Transformation from committed progenitor to leukaemia stem cell initiated by MLL–AF9Nature, 2006
- Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome predictionBlood, 2006